Some people using Cequa eye drops developed urinary tract infections (UTIs) in clinical trials of the drug. Between 1% and 5% of people who used Cequa reported UTIs.

The eye drops and solutions were shipped between May 26, 2023 and April 21, 2025. Recalled products include: • 13,104 cases of Lubricant Eye Drops Solution; national drug code NDC 50268-126-15 ...

• 13,104 cases of Lubricant Eye Drops Solution; national drug code NDC 50268-126-15 • 32,876 cases of Carboxymethylcellulose Sodium Ophthalmic Solution; NDC 50268-068-15 ...

32,876 cases of Carboxymethylcellulose Sodium Ophthalmic Solution (National Drug Code: 50268-068-15) 13,104 cases of Lubricant Eye Drops Solution (National Drug Code: 50268-126-15) ...

The recall encompasses five products, totaling over 75,000 cases of ophthalmic solution, shipped over a two-year period: May 26, 2023, to April 21, 2025. The products include: ...

Restasis (cyclosporine) is a brand-name prescription drug that’s used to treat chronic dry eye. Learn about side effects, warnings, dosage, and more.

Systane Lubricant Eye Drops in a green and pink carton design, with “Systane” and “ULTRA PF” brand names on the front of the carton, and the “25 vials” package size marked Lot 10101 ...

Overview: Atropine ophthalmic is an eye drop used to dilate the pupils and relax eye muscles before eye exams or procedures. It is also used to treat lazy eye. The most common side effects are ...

The eye drop recall of 2023 is stating to seep into 2024. Here's everything you need to know, including the full list of brands being recalled.